1336 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) INDEPENDENTLY PREDICTS TYPE-2 DIABETES AND PRE-DIABETES DURING A SEVEN-YEAR PROSPECTIVE FOLLOW-UP

Journal of Hepatology ◽

10.1016/s0168-8278(12)61347-6 ◽

2012 ◽

Vol 56 ◽

pp. S526

Author(s):

S. Zelber-Sagi ◽

R. Lotan ◽

O. Shibolet ◽

M. Webb ◽

A. Buch ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?

Endocrine Abstracts ◽

10.1530/endoabs.56.gp74 ◽

2018 ◽

Author(s):

Carolina M Perdomo ◽

Javier Gargallo ◽

Maria Llavero ◽

Marta Garcia ◽

Alejandro Bojorquez ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Diabetic Complications ◽

Fatty Liver Disease ◽

Liver Stiffness ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Dynamics of indicators of cytolysis, carbonyl stress in patients with type 2 diabetes and non-alcoholic fatty liver disease on glucose-lowering therapies

Endocrine Abstracts ◽

10.1530/endoabs.70.ep218 ◽

2020 ◽

Author(s):

Rodionova Svetlana ◽

Zvenigorodskaya Larissa ◽

Biryukova Elena ◽

Petrakov Alexander ◽

Nilova Tamara

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Carbonyl Stress ◽

Alcoholic Fatty Liver ◽

Glucose Lowering ◽

Alcoholic Fatty Liver Disease

Download Full-text

Evaluation the Predictors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients

Systematic Reviews in Pharmacy ◽

10.31838/srp.2020.5.58 ◽

2020 ◽

Vol 11 (05) ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Faculty Opinions recommendation of Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726338986.793542219 ◽

2018 ◽

Author(s):

Miriam Vos

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Causal Association ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Dapagliflozin reduces hepatic and visceral fat in type‐2 diabetes patients with non‐alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.15580 ◽

2021 ◽

Author(s):

Susrichit Phrueksotsai ◽

Kanokwan Pinyopornpanish ◽

Juntima Euathrongchit ◽

Apinya Leerapun ◽

Arintaya Phrommintikul ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Visceral Fat ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease ◽

Diabetes Patients

Download Full-text

Non‐alcoholic fatty liver disease in type 2 diabetes – A specific entity?

Liver International ◽

10.1111/liv.14846 ◽

2021 ◽

Vol 41 (S1) ◽

pp. 105-111

Author(s):

Benjamin Schröder ◽

Sabine Kahl ◽

Michael Roden

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control

Journal of Diabetes ◽

10.1111/1753-0407.12566 ◽

2017 ◽

Vol 9 (8) ◽

pp. 722-723

Author(s):

Zachary Bloomgarden

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Glycemic Control ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease

Gastroenterology Review ◽

10.5114/pg.2018.79815 ◽

2018 ◽

Vol 13 (4) ◽

pp. 337-339

Author(s):

Dimitrios Patoulias ◽

Maria Kalogirou

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Disease Type ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Terapêutica disponível para a Doença hepática gordurosa não alcoólica e sua relação com a evolução do diabetes melito tipo 2: uma revisão de literatura / Available therapy for non-alcoholic fatty liver disease and its relationship with the evolution of type 2 diabetes mellitus: a literature review

Brazilian Journal of Health Review ◽

10.34119/bjhrv3n4-364 ◽

2020 ◽

Vol 3 (4) ◽

pp. 11131-11145

Author(s):

Diego Handeri Hermes ◽

Sersie Lessa Antunes Costa Almeida ◽

Alice Faria Santos Fernandes ◽

Diogo Ordones Delfraro ◽

Helena Ribeiro de Oliveira ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Liver Disease ◽

Literature Review ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes and Non‐Alcoholic Fatty Liver Disease: A Multicenter, Double‐blind, Randomized, Comparative trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14623 ◽

2021 ◽

Author(s):

Eugene Han ◽

Ji Hye Huh ◽

Eun Young Lee ◽

Ji Cheol Bae ◽

Sung Wan Chun ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Comparative Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text